177 related articles for article (PubMed ID: 16100966)
1. Botulinum toxin a in the treatment of blepharospasm: a 10-year experience.
Silveira-Moriyama L; Gonçalves LR; Chien HF; Barbosa ER
Arq Neuropsiquiatr; 2005 Jun; 63(2A):221-4. PubMed ID: 16100966
[TBL] [Abstract][Full Text] [Related]
2. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience.
Barbosa ER; Takada LT; Gonçalves LR; Costa RM; Silveira-Moriyama L; Chien HF
Arq Neuropsiquiatr; 2010 Aug; 68(4):502-5. PubMed ID: 20730300
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
Cardoso F
Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
[TBL] [Abstract][Full Text] [Related]
6. Blepharospasm with non-satisfactory response to treatment: our experience with IncobotulinumtoxinA.
Ricciardi L; Ialongo T; Guidubaldi A; Di Giacopo R; Bentivoglio AR
Parkinsonism Relat Disord; 2014 Jun; 20(6):665-7. PubMed ID: 24685658
[No Abstract] [Full Text] [Related]
7. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
Vargel I; Canter HI; Topaloglu H; Erk Y
J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department.
Tomić A; Vujović B; Svetel M; Misković ND; Petrović I; Pekmezović T; Kostić VS
Vojnosanit Pregl; 2015 Dec; 72(12):1069-73. PubMed ID: 26898029
[TBL] [Abstract][Full Text] [Related]
9. Treatment of blepharospasm with botulinum neurotoxin type A: long-term results.
Calace P; Cortese G; Piscopo R; Della Volpe G; Gagliardi V; Magli A; De Berardinis T
Eur J Ophthalmol; 2003 May; 13(4):331-6. PubMed ID: 12872788
[TBL] [Abstract][Full Text] [Related]
10. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with frontalis sling operation in the treatment of essential blepharospasm unresponsive to botulinum toxin therapy.
Wabbels B; Roggenkämper P
Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):45-50. PubMed ID: 16874524
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported benefit from botulinum toxin treatment for essential blepharospasm: using 2 assessment scales.
Lee RM; Chowdhury HR; Hyer JN; Smith HB; Jones CA
Ophthalmic Plast Reconstr Surg; 2013; 29(3):196-7. PubMed ID: 23446304
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional structured survey of patients receiving botulinum toxin type A treatment for blepharospasm.
Fezza J; Burns J; Woodward J; Truong D; Hedges T; Verma A
J Neurol Sci; 2016 Aug; 367():56-62. PubMed ID: 27423565
[TBL] [Abstract][Full Text] [Related]
14. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
[TBL] [Abstract][Full Text] [Related]
15. Injecting botulinum toxin into the treatment of blepharospasm.
Popescu MN; Popescu SI; Cernat CC; Boariu AM; Călin E; Vieru A; Muşat O
Rom J Ophthalmol; 2018; 62(2):162-165. PubMed ID: 30206561
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China.
Fang XB; Xie MS; Song ZB; Zhong ZG; Wang Y; Ou ZL; Dang C; Li L; Zhang WX
Neurol Sci; 2020 Mar; 41(3):645-652. PubMed ID: 31745757
[TBL] [Abstract][Full Text] [Related]
17. Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.
Lee S; Park S; Lew H
Korean J Ophthalmol; 2018 Feb; 32(1):1-7. PubMed ID: 29376224
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
Bhidayasiri R; Cardoso F; Truong DD
Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated.
Batisti JP; Kleinfelder AD; Galli NB; Moro A; Munhoz RP; Teive HA
Arq Neuropsiquiatr; 2017 Feb; 75(2):87-91. PubMed ID: 28226076
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A therapy for blepharospasm.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
